This supports the loss of VAPB function in ALS8 pathogenesis and suggests that reducing intracellular PtdIns4P might be an effective therapeutic strategy in delaying progressive loss of motor neurons. The gene discussed is VAPB; the disease is amyotrophic lateral sclerosis type 8.